Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Compensating for loss of neurodegenerative disease gene ATM offers insights into cancer drug resistance

firstwordpharmaJanuary 09, 2019

Tag: cancer drug , gene ATM , neurodegenerative disease , cancer drug

PharmaSources Customer Service